Skip to main navigation
  • HOME
  • ABOUT ENZON
  • ROYALTY PRODUCTS
  • INVESTORS & MEDIA

    Investor Relations

    • Press Releases
    • Corporate Governance
    • SEC Filings
    • Stock Quote
    • Stock Lookup
    • Contact Us
  • CONTACT US
  • Request Information
  • Email Alerts
  • Download Library
  • RSS News Feeds
Shareholder Tools
Downloads
Print

Downloads

Nov 03, 2011
Enzon Reports 3rd Quarter 2011 Results 70.7 KB
Oct 17, 2011
Enzon Announces Management Change, Forms Special Committee of the Board 12.1 KB
Sep 22, 2011
Enzon Announces Reduction in Force to Align Operations with Research and Development Activities 10.5 KB
Aug 04, 2011
Enzon Reports 2nd Quarter 2011 Results 73 KB
May 31, 2011
ENZON Names Ana I. Stancic Chief Financial Officer 13 KB
May 19, 2011
Enzon Announces Discontinuation of PEG-SN38 Program in Metastatic Colorectal Carcinoma in Light of Evolving Standards of Care 11.7 KB
May 10, 2011
2010 Annual Report 1.6 MB
May 10, 2011
2011 Proxy Statement 885.5 KB
May 06, 2011
Enzon Reports 1st Quarter 2011 Results 85.8 KB
Apr 05, 2011
Enzon Presents Data at 2011 AACR Meeting 69 KB

Pagination

  • First page « first
  • Previous page ‹ previous
  • Page 1
  • Page 2
  • Current page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • …
  • Next page next ›
  • Last page last »

©2025 Enzon Pharmaceuticals, Inc., All Rights Reserved.